• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素-λ 4 中的遗传变异影响中国汉族人群 HCV 的清除。

Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population.

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China.

Department of Infectious Diseases, the People's Hospital of Jiangsu Province, Nanjing 210029, China.

出版信息

Sci Rep. 2017 Feb 10;7:42408. doi: 10.1038/srep42408.

DOI:10.1038/srep42408
PMID:28186161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5301237/
Abstract

Recent many studies indicated a novel dinucleotide variant in ss469415590 (TT vs. ΔG) of interferon-λ 4 (IFNL4) gene strongly associated with hepatitis C virus clearance. To evaluate the impact and clinical usefulness of IFNL4 ss469415590 genotype on predicting both spontaneous HCV clearance and response to therapy in Chinese population, we genotyped 795 chronic HCV carriers, 460 subjects with HCV natural clearance and 362 patients with pegylated interferon-α and ribavirin (PEG IFN-α/RBV) treatment. IFNL4 ss469415590 variant genotypes significantly decreased host HCV clearance, both spontaneous (dominant model: OR = 0.50, 95% CI = 0.36-0.71) and IFN-α induced (dominant model: OR = 0.32, 95% CI = 0.18-0.56). Multivariate stepwise analysis indicated that ss469415590, rs12979860, the level of baseline HCV RNA and platelet were as independent predictors for sustained virological response (SVR). But the area under the ROC curve (AUC) was only 0.58 for ss469415590, and it was elevated to 0.71 by adding rs12979860, baseline HCV RNA and platelet in the prediction model of SVR. Therefore, these findings underscore that although genetic factors of host and pathogen were commonly important during HCV clearance, ss469415590 may be also a strongly predictive marker in the Chinese population.

摘要

最近的许多研究表明,干扰素-λ 4(IFNL4)基因中的新型二核苷酸变异 ss469415590(TT 对 ΔG)与丙型肝炎病毒清除强烈相关。为了评估 IFNL4 ss469415590 基因型对预测中国人群自发 HCV 清除和对治疗反应的影响和临床实用性,我们对 795 例慢性 HCV 携带者、460 例 HCV 自然清除者和 362 例聚乙二醇干扰素-α和利巴韦林(PEG IFN-α/RBV)治疗患者进行了基因分型。IFNL4 ss469415590 变异基因型显著降低了宿主 HCV 的清除率,无论是自发清除(显性模型:OR=0.50,95%CI=0.36-0.71)还是 IFN-α 诱导清除(显性模型:OR=0.32,95%CI=0.18-0.56)。多变量逐步分析表明,ss469415590、rs12979860、基线 HCV RNA 水平和血小板计数是持续病毒学应答(SVR)的独立预测因素。但是,ss469415590 的 ROC 曲线下面积(AUC)仅为 0.58,通过在 SVR 预测模型中添加 rs12979860、基线 HCV RNA 和血小板,AUC 升高至 0.71。因此,这些发现强调了尽管宿主和病原体的遗传因素在 HCV 清除过程中通常很重要,但 ss469415590 在中国人群中也可能是一个强有力的预测标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e72e/5301237/a1a7c44f8680/srep42408-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e72e/5301237/a6c8f8e89f41/srep42408-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e72e/5301237/2bf1c4378fa5/srep42408-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e72e/5301237/a1a7c44f8680/srep42408-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e72e/5301237/a6c8f8e89f41/srep42408-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e72e/5301237/2bf1c4378fa5/srep42408-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e72e/5301237/a1a7c44f8680/srep42408-f3.jpg

相似文献

1
Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population.干扰素-λ 4 中的遗传变异影响中国汉族人群 HCV 的清除。
Sci Rep. 2017 Feb 10;7:42408. doi: 10.1038/srep42408.
2
IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection.IFNL4基因ss469415590多态性对慢性丙型肝炎病毒1b型感染患者的治疗决策有影响,但对2a型感染患者无影响。
Infect Genet Evol. 2016 Apr;39:132-140. doi: 10.1016/j.meegid.2016.01.020. Epub 2016 Jan 26.
3
Correlation of interferon-lambda 4 ss469415590 with the hepatitis C virus treatment response and its comparison with interleukin 28b polymorphisms in predicting a sustained virological response: a meta-analysis.干扰素-λ4基因ss469415590与丙型肝炎病毒治疗反应的相关性及其在预测持续病毒学应答方面与白细胞介素28b基因多态性的比较:一项荟萃分析
Int J Infect Dis. 2016 Dec;53:52-58. doi: 10.1016/j.ijid.2016.10.023. Epub 2016 Oct 31.
4
Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection.泰国人群中胸腺嘧啶 - 腺嘌呤二核苷酸重复序列、IL28B和IFNL4的患病率及其与丙型肝炎感染自发清除和治疗结果的相关性
PLoS One. 2015 May 4;10(5):e0125400. doi: 10.1371/journal.pone.0125400. eCollection 2015.
5
The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.IL28B、IFNL4和HLA基因的遗传变异对慢性丙型肝炎病毒感染治疗反应的影响。
Infect Genet Evol. 2017 Oct;54:330-337. doi: 10.1016/j.meegid.2017.07.023. Epub 2017 Jul 21.
6
IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians.IFNL4基因的ss469415590变异在预测高加索人丙型肝炎病毒1型或4型治疗反应方面,表现出与rs12979860相似的性能。
PLoS One. 2014 Apr 18;9(4):e95515. doi: 10.1371/journal.pone.0095515. eCollection 2014.
7
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.干扰素-λ4 和 IL28B 多态性 - 对慢性丙型肝炎患者干扰素/利巴韦林治疗反应的影响。
Aliment Pharmacol Ther. 2014 Jan;39(1):104-11. doi: 10.1111/apt.12547. Epub 2013 Nov 10.
8
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.在真实临床环境中,丙型肝炎病毒2/3型慢性丙型肝炎(CHC)患者中干扰素-λ3和干扰素-λ4基因分型的性能和价值
PLoS One. 2015 Dec 23;10(12):e0145622. doi: 10.1371/journal.pone.0145622. eCollection 2015.
9
Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.干扰素 lambda4 基因多态性与活体供肝移植后丙型肝炎病毒复发的治疗反应相关。
J Viral Hepat. 2014 Jun;21(6):397-404. doi: 10.1111/jvh.12154. Epub 2013 Aug 5.
10
IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients.IFNL4和IFNL3相关多态性强烈影响丙型肝炎病毒感染患者中干扰素-α受体-1的自发表达。
PLoS One. 2015 Feb 12;10(2):e0117397. doi: 10.1371/journal.pone.0117397. eCollection 2015.

引用本文的文献

1
Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay?丙型肝炎病毒遗传变异性、人体免疫反应和基因组多态性:它们之间的相互作用是什么?
Cells. 2019 Apr 3;8(4):305. doi: 10.3390/cells8040305.

本文引用的文献

1
Association of polymorphisms in HLA antigen presentation-related genes with the outcomes of HCV infection.HLA抗原呈递相关基因多态性与丙型肝炎病毒感染结局的关联
PLoS One. 2015 Apr 13;10(4):e0123513. doi: 10.1371/journal.pone.0123513. eCollection 2015.
2
Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians.IFNL3.rs12979860和IFNL4.ss469415590基因多态性对埃及丙型肝炎病毒感染清除的影响。
Hepatol Int. 2015 Apr;9(2):251-7. doi: 10.1007/s12072-015-9619-z. Epub 2015 Mar 12.
3
IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens.
IFNL4基因ss469415590变异与接受含干扰素方案治疗的日本丙型肝炎病毒1型感染患者的治疗反应相关。
Int J Hepatol. 2014;2014:723868. doi: 10.1155/2014/723868. Epub 2014 Dec 8.
4
Genetic variants in antigen presentation-related genes influence susceptibility to hepatitis C virus and viral clearance: a case control study.抗原呈递相关基因的遗传变异影响丙型肝炎病毒易感性和病毒清除率:一项病例对照研究。
BMC Infect Dis. 2014 Dec 21;14:716. doi: 10.1186/s12879-014-0716-8.
5
Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance.在预测丙型肝炎病毒1型(HCV-1)治疗诱导的病毒清除方面,编码干扰素λ-3和λ-4的基因变异情况。
Liver Int. 2014 Oct;34(9):1369-77. doi: 10.1111/liv.12411. Epub 2013 Dec 23.
6
IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians.IFNL4基因的ss469415590变异在预测高加索人丙型肝炎病毒1型或4型治疗反应方面,表现出与rs12979860相似的性能。
PLoS One. 2014 Apr 18;9(4):e95515. doi: 10.1371/journal.pone.0095515. eCollection 2014.
7
Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C.干扰素λ4基因多态性对慢性丙型肝炎患者接受特拉匹韦、聚乙二醇干扰素和利巴韦林联合治疗疗效的影响。
Hepatol Res. 2014 Dec;44(14):E447-54. doi: 10.1111/hepr.12336. Epub 2014 May 6.
8
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.达卡他韦联合索非布韦治疗既往治疗或未经治疗的慢性 HCV 感染。
N Engl J Med. 2014 Jan 16;370(3):211-21. doi: 10.1056/NEJMoa1306218.
9
Genetic polymorphism in IFNL4 and response to pegylated interferon-α and ribavirin in Japanese chronic hepatitis C patients.日本慢性丙型肝炎患者中IFNL4基因多态性与聚乙二醇化干扰素-α和利巴韦林治疗反应的关系
Tissue Antigens. 2014 Jan;83(1):45-8. doi: 10.1111/tan.12264.
10
The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection.新型 ss469415590 变异可预测慢性丙型肝炎病毒 1 型感染患者对治疗的病毒学应答。
Aliment Pharmacol Ther. 2014 Feb;39(3):322-30. doi: 10.1111/apt.12568. Epub 2013 Dec 5.